Resveratrol STUDIES

Highlights Randomized, double-blind, placebo-controlled, cross-over trial with 22 healthy adults Supplementation consists of single doses of 99% pure trans-resveratrol (250 mg or 500 mg) Resveratrol increases cerebral blood flow during cognitive performance, compared to...

Highlights Randomized, double-blind, placebo-controlled trial with 72 post-menopausal women Supplementation consisted of resVida® resveratrol (75 mg/day, twice daily) for 14 weeks Compared to placebo, resVida® significantly improved cerebrovascular responsiveness by...

Highlights Randomized, double-blind, placebo-controlled, cross-over trial with 11 obese, but otherwise healthy men. Supplementation consists of resVida® resveratrol (150 mg/day for 30 days) Compared to placebo, resVida® induces significant metabolic...

Highlights Randomized, double-blind, placebo-controlled, cross-over trial with 28 obese, but otherwise healthy adults. Supplementation consists of resVida® resveratrol (75 mg/day for 6 weeks) Compared to placebo, resVida® significantly improves flow-mediated...

Highlights Randomized, double-blind, placebo-controlled trial with 36 dementia-free adults with type 2 diabetes Supplementation consists of single doses of resVida® (75, 150, and 300mg) at weekly intervals Compared to placebo,...